Galenical formulation

Details Galenical formulation Galenical formulation

2004-04-28

2008-03-18

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C549S400000, C549S401000, C549S403000, C544S353000, C548S305100, C548S305400, C514S249000, C514S393000

Reexamination Certificate

active

07345090

ABSTRACT:
The invention relates to compounds of the formula Iwhere R1, R2, R3, R4and R5have the meanings given in claim 1. The compound is suitable in particular for use in skin care compositions. They protect, firstly, against harmful oxidation reactions and, secondly, also act as UV filters.

REFERENCES:
patent: 5665367 (1997-09-01), Burger
patent: 5718906 (1998-02-01), Martin
patent: 5952373 (1999-09-01), Lanzendorfer
patent: 6121243 (2000-09-01), Lanzendorfer
patent: 6180662 (2001-01-01), Lanzendorfer
patent: 19 508 608 (1995-09-01), None
patent: 0 716 847 (1995-11-01), None
patent: 2 687 572 (1992-02-01), None
patent: 2 687 572 (1993-08-01), None
patent: 2 708 851 (1995-02-01), None
Samejima et al., CAPLUS Abstract 130:65484, 1998.
Joon-Su Shin, et al., “Synthesis and Hypoglycemic Effect of Chrysin Derivatives”, Bioorganic & Medicinal Chemistry Letters 9, (1999), pp. 869-874.
Kim et al., CAPLUS Abstract 132:251003, 1999.
Shin et al., CAPLUS Abstract 131:58671, 1999.
English Abstract of FR 2687572, 1992.
English Abstract of FR 2708851, 1995.

Affiliated with

Also associated with

Rating

Galenical formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Galenical formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Galenical formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3980872